Cargando…
Fasting Reduces the Incidence of Delayed-Type Vomiting Associated with Doxorubicin Treatment in Dogs with Lymphoma()
Fasting reduces gastrointestinal cellular proliferation rates through G(1) cycle blockade and can promote cellular protection of normal but not cancer cells through altered cell signaling including down-regulation of insulin-like growth factor 1 (IGF-1). Consequently, the purpose of this study was t...
Autores principales: | Withers, Sita S., Kass, Philip H., Rodriguez, Carlos O., Skorupski, Katherine A., O’Brien, Danielle, Guerrero, Teri A., Sein, Kristen D., Rebhun, Robert B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4145391/ https://www.ncbi.nlm.nih.gov/pubmed/24831580 http://dx.doi.org/10.1016/j.tranon.2014.04.014 |
Ejemplares similares
-
Retrospective analysis of doxorubicin and prednisone as first-line therapy for canine B-cell lymphoma
por: Al-Nadaf, Sami, et al.
Publicado: (2018) -
Risk factors associated with progressive increases in serum creatinine concentrations in cats with cancer receiving doxorubicin
por: Kopecny, Lucy, et al.
Publicado: (2020) -
Randomized Phase III Trial of Piroxicam in Combination with Mitoxantrone or Carboplatin for First‐Line Treatment of Urogenital Tract Transitional Cell Carcinoma in Dogs
por: Allstadt, S.D., et al.
Publicado: (2015) -
Bacterial Urinary Tract Infections Associated with Transitional Cell Carcinoma in Dogs
por: Budreckis, D.M., et al.
Publicado: (2015) -
Frequency and Severity of Neutropenia Associated with Food and Drug Administration Approved and Compounded Formulations of Lomustine in Dogs with Cancer
por: Burton, J.H., et al.
Publicado: (2016)